Protein Tyrosine Phosphatase SHP-2 (PTPN11) in Hematopoiesis and Leukemogenesis
Author(s) -
Xia Liu,
ChengKui Qu
Publication year - 2011
Publication title -
journal of signal transduction
Language(s) - English
Resource type - Journals
eISSN - 2090-1739
pISSN - 2090-1747
DOI - 10.1155/2011/195239
Subject(s) - ptpn11 , noonan syndrome , protein tyrosine phosphatase , phosphatase , cancer research , haematopoiesis , medicine , germline , signal transduction , pathogenesis , germline mutation , somatic cell , mutation , immunology , microbiology and biotechnology , phosphorylation , biology , genetics , gene , stem cell , kras
SHP-2 ( PTPN11 ), a ubiquitously expressed protein tyrosine phosphatase, is critical for hematopoietic cell development and function owing to its essential role in growth factor/cytokine signaling. More importantly, germline and somatic mutations in this phosphatase are associated with Noonan syndrome, Leopard syndrome, and childhood hematologic malignancies. The molecular mechanisms by which SHP-2 mutations induce these diseases are not fully understood, as the biochemical bases of SHP-2 functions still remain elusive. Further understanding SHP-2 signaling activities and identification of its interacting proteins/substrates will shed light on the pathogenesis of PTPN11 -associated hematologic malignancies, which, in turn, may lead to novel therapeutics for these diseases.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom